Giovannacci I, Vescovi P, Manfredi M, Meleti M. Non-invasive visual tools for diagnosis of oral cancer and dysplasia: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 May 1;21 (3):e305-15.  

 

 

doi:10.4317/medoral.20996

http://dx.doi.org/doi:10.4317/medoral.20996

 

 

1. Dissanayaka WL, Pitiyage G, Kumarasiri PV, Liyanage RL, Dias KD, Tilakaratne WM. Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:518-25.
http://dx.doi.org/10.1016/j.oooo.2011.11.001

 

2. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001;2:239-51.
http://dx.doi.org/10.2165/00128071-200102040-00005

 

3. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009;1:5.
http://dx.doi.org/10.1186/1758-3284-1-5

 

4. Navone R, Burlo P, Pich A, Pentenero M, Broccoletti R, Marsico A, et al. The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. Cytopathology. 2007;18:356-60.
http://dx.doi.org/10.1111/j.1365-2303.2006.00402.x

 

5. Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol. 2011;3:33.
http://dx.doi.org/10.1186/1758-3284-3-33

 

6. Petruzzi M, Lucchese A, Nardi GM, Lauritano D, Favia G, Serpico R, et al. Evaluation of autofluorescence and toluidine blue in the differentiation of oral dysplastic and neoplastic lesions from non dysplastic and neoplastic lesions: a cross-sectional study. J Biomed Opt. 2014;19:76003.
http://dx.doi.org/10.1117/1.JBO.19.7.076003

 

7. KŠmmerer PW, Rahimi-Nedjat RK, Ziebart T, Bemsch A, Walter C, Al-Nawas B, et al. A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions-clinical evaluation and review of the literature. Clin Oral Investig. 2015;19:459-66.
http://dx.doi.org/10.1007/s00784-014-1252-z

 

8. Pallagatti S, Sheikh S, Aggarwal A, Gupta D, Singh R, Handa R, et al. Toluidine blue staining as an adjunctive tool for early diagnosis of dysplastic changes in the oral mucosa. J Clin Exp Dent. 2013;5:e187-91.
http://dx.doi.org/10.4317/jced.51121

 

9. Mittal N, Palaskar S, Shankari M. Rose Bengal staining - diagnostic aid for potentially malignant and malignant disorders: a pilot study. Indian J Dent Res. 2012;23:561-4.
http://dx.doi.org/10.4103/0970-9290.107326

 

10. McNamara KK, Martin BD, Evans EW, Kalmar JR. The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:636-43.
http://dx.doi.org/10.1016/j.oooo.2012.07.484

 

11. Awan Kh, Yang Y, Morgan P, Warnakulasuriya S. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment. Oral Dis. 2012;18:728-33.
http://dx.doi.org/10.1111/j.1601-0825.2012.01935.x

 

12. Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions. J Craniofac Surg. 2012;23:e162-4.
http://dx.doi.org/10.1097/SCS.0b013e31824cdbea

 

13. Farah CS, McIntosh L, Georgiou A, McCullough MJ. Efficacy of tissue autofluorescence imaging (VELScope) in the visualization of oral mucosal lesions. Head Neck. 2012;34:856-62.
http://dx.doi.org/10.1002/hed.21834

 

14. Paderni C, Compilato D, Carinci F, Nardi G, Rodolico V, Lo Muzio L, et al. Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring. Int J Immunopathol Pharmacol. 2011;24(2 Suppl):121-8.

 

15. Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLiteŠ) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med. 2011;40:541-4.
http://dx.doi.org/10.1111/j.1600-0714.2011.01048.x

 

16. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscopeŠ) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011;47:274-7.
http://dx.doi.org/10.1016/j.oraloncology.2011.02.001

 

17. Moro A, Di Nardo F, Boniello R, Marianetti TM, Cervelli D, Gasparini G, et al. Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer. J Craniofac Surg. 2010;21:1899-903.
http://dx.doi.org/10.1097/SCS.0b013e3181f4afb4

 

18. Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W. Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial. Clin Oral Investig. 2011;15:975-82.
http://dx.doi.org/10.1007/s00784-010-0455-1

 

19. Sieroń A, Kościarz-Grzesiok A, Waśkowska J, Kawczyk-Krupka A, Misiak A, Koszowski R, et al. The role of autofluorescence diagnostics in the oral mucosa diseases. Photodiagnosis Photodyn Ther. 2008;5:182-6.
http://dx.doi.org/10.1016/j.pdpdt.2008.09.002

 

20. Schwarz RA, Gao W, Redden Weber C, Kurachi C, Lee JJ, El-Naggar AK, et al. Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer. 2009;115:1669-79.
http://dx.doi.org/10.1002/cncr.24177

 

21. Mallia RJ, Thomas SS, Mathews A, Kumar R, Sebastian P, Madhavan J, et al. Laser-induced autofluorescence spectral ratio reference standard for early discrimination of oral cancer. Cancer. 2008;112:1503-12.
http://dx.doi.org/10.1002/cncr.23324

 

22. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008;44:538-44.
http://dx.doi.org/10.1016/j.oraloncology.2007.08.011

 

23. Du GF, Li CZ, Chen HZ, Chen XM, Xiao Q, Cao ZG, et al. Rose bengal staining in detection of oral precancerous and malignant lesions with colorimetric evaluation: a pilot study. Int J Cancer. 2007;120:1958-63.
http://dx.doi.org/10.1002/ijc.22467

 

24. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006;11:024006.
http://dx.doi.org/10.1117/1.2193157

 

25. Sharwani A, Jerjes W, Salih V, Swinson B, Bigio IJ, El-Maaytah M, et al. Assessment of oral premalignancy using elastic scattering spectroscopy. Oral Oncol. 2006;42:343-9.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.008

 

26. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:535-40.
http://dx.doi.org/10.1067/moe.2001.112949

 

27. Leunig A, Betz CS, Mehlmann M, Stepp H, Arbogast S, Grevers G, et al. Detection of squamous cell carcinoma of the oral cavity by imaging 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Laryngoscope. 2000;110:78-83.
http://dx.doi.org/10.1097/00005537-200001000-00015

 

28. Martin IC, Kerawala CJ, Reed M. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:444-6.
http://dx.doi.org/10.1016/S1079-2104(98)90071-3

 

29. Bhatia N, Matias MA, Farah CS. Assessment of a decision making protocol to improve the efficacy of VELscopeŠ in general dental practice: a prospective evaluation. Oral Oncol. 2014;50:1012-9.
http://dx.doi.org/10.1016/j.oraloncology.2014.07.002

 

30. Francisco AL, Correr WR, Azevedo LH, Kern VG, Pinto CA, Kowalski LP, et al. Fluorescence spectroscopy for the detection of potentially malignant disorders and squamous cell carcinoma of the oral cavity. Photodiagnosis Photodyn Ther. 2014;11:82-90.
http://dx.doi.org/10.1016/j.pdpdt.2014.03.009

 

31. Guze K, Pawluk HC, Short M, Zeng H, Lorch J, Norris C, et al. Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck. 2015;37:511-7.
http://dx.doi.org/10.1002/hed.23629

 

32. Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M, et al. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscopeŠ) - a single blinded clinical evaluation. Head Face Med. 2013;9:23.
http://dx.doi.org/10.1186/1746-160X-9-23

 

33. Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev. 2012;21:460-6.
http://dx.doi.org/10.1097/CEJ.0b013e32834fdb6d

 

34. Cancela-Rodr’guez P, Cerero-Lapiedra R, Esparza-G—mez G, Llamas-Mart’nez S, Warnakulasuriya S. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions. J Oral Pathol Med. 2011;40:300-4.
http://dx.doi.org/10.1111/j.1600-0714.2010.00985.x

 

35. Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010;141:151-6.
http://dx.doi.org/10.14219/jada.archive.2010.0132

 

36. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions.J Oral Maxillofac Surg. 2007;65:424-6.
http://dx.doi.org/10.1016/j.joms.2006.10.055

 

37. Chen YW, Lin JS, Fong JH, Wang IK, Chou SJ, Wu CH, et al. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. Br J Oral Maxillofac Surg. 2007;45:590-1.
http://dx.doi.org/10.1016/j.bjoms.2006.08.017

 

38. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg. 2005;34:521-7.
http://dx.doi.org/10.1016/j.ijom.2004.10.008

 

39. Warnakulasuriya KA, Johnson NW. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med. 1996;25:97-103.
http://dx.doi.org/10.1111/j.1600-0714.1996.tb00201.x